Sunitinib
Inquiry
| Post Date: | Jan 22,2018 |
| Expiry Date: | Jan 22,2019 |
| Detailed Description: |
Cas No. :557795-19-4
Quantity: 8Kilograms Payment Method: 100% T/T in advance Sunitinib is a cancer medicine that interferes with the growth and spread of cancer cells in the body and used to treat certain types of advanced or progressive tumors of the digestive system, the pancreas, or the kidneys. |
| CAS Registry Number: | 557795-19-4 |
| Synonyms: | ;sunitinib base;n-(2-diethylaminoethyl)-5-[(z)-(5-fluoro-2-oxo-indolin-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide;1h-pyrrole-3-carboxamide, n-(2-(diethylamino)ethyl)-5-((z)- (5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl)-2,4- Dimethyl-;n-(2-(diethylamino)ethyl)-5-((z)-(5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl)-2,4-dimethyl-1h-pyrrole-3-carboxamide;N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide (2Z)-but-2-enedioate;Sulitinib; |
| Molecular Formula: | C26H31FN4O6 |
| Molecular Weight: | 514.5459 |
| Molecular Structure: | 
|
| Company: | Shandong Langnuo Pharmaceutical Co., Ltd. [ China ] |
| Contact: | Jacqueline |
| Tel: | +86-531-88116033 |
| Fax: | +86-531-88115352 |
| Email: | export@bestcomm.cn |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
